Treating arteriosclerosis using benzimidazole compositions
US5387600A · kind A · utility
9Cited by
2References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 21, 1993 |
| Grant date | Feb 7, 1995 |
| Priority date | — |
| Expiry date | Jul 21, 2013 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P25/08
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed are an antihyperlipidemia or antiarteriosclerosis agent comprising a certain benzimidazole or 2,2'-methylenebisphenol derivative such as 5-dodecanoylamino-2-mercaptobenzimidazole or 2,2'-isobutylidenebis(4,6-dimethyphenol).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.